Head and Neck Cancer
A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig as Sequential Therapy Versus Observation in Participants with Unresected Locally Advanced-Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC), D798EC00001
- Details
ClinicalTrials.gov ID:
NCT06129864
Diagnosis Type:
NA
USOR Number:
- Address
,
P: